As of Mar 27
| +0.60 / +0.76%|
The 16 analysts offering 12-month price forecasts for Charles River Laboratories International Inc have a median target of 75.00, with a high estimate of 88.00 and a low estimate of 55.00. The median estimate represents a -5.79% decrease from the last price of 79.61.
The current consensus among 22 polled investment analysts is to Hold stock in Charles River Laboratories International Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.